← Open Payments lookup

MEGAN TERRELL: Open Payments

NPI 1124724679 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,845 in 98 payments from 21 companies in 2025. Trend: 2023 $1,870 · 2024 $2,272 · 2025 $1,845

Food & beverage: $1,845
CompanyPaymentsAmount
Madrigal Pharmaceuticals11$231
ABBVIE INC.12$199
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$147
Ardelyx, Inc.7$135
Takeda Pharmaceuticals U.S.A., Inc.7$133
GENZYME CORPORATION6$133
QOL Medical, LLC5$116
Aimmune Therapeutics, Inc.7$112
Ipsen Biopharmaceuticals, Inc5$101
Gilead Sciences, Inc.4$95

Products named: REZDIFFRA, DUPIXENT, IBSRELA, ENTYVIO, Sucraid, ZENPEP, IQIRVO, RELISTOR.

Industry payments across AL — which companies pay providers there.